CytomX Therapeutics Announces Appointment of Charles Fuchs, M.D., M.P.H., to the Board of Directors

Go back to CytomX Therapeutics Announces Appointment of Charles Fuchs, M.D., M.P.H., to the Board of Directors
Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) Delayed: 3.45 +0.01 (0.29%)
Previous Close $3.44    52 Week High $24.68 
Open $3.42    52 Week Low $9.10 
Day High $3.50    P/E N/A 
Day Low $3.37    EPS $0.00 
Volume 1,698,607